TCRT October 2007

category image Volume 6
No. 5 (p 361-588)
October 2007
ISSN 1533-0338
Ultrasound-aided Therapy

Ultrasound-enhanced Chemotherapy and Gene Delivery for Glioma Cells (p. 433-442)

Treatment of brain cancer is limited in part by inefficient intracellular delivery of drugs and DNA for chemotherapy and gene therapy, respectively. This study tested the hypothesis that ultrasound may be used to enhance intracellular delivery and efficacy of chemotherapeutics and genes in glioma cells in vitro. First, suitable ultrasound conditions were identified by measuring intracellular uptake of calcein and viability of GS 9L rat gliosarcoma cells after a range of different ultrasound exposures. We selected sonication at 10 J/cm2, which achieved intracellular delivery of ∼106 molecules/cell. Next, glial cells were sonicated with varying concentrations of model chemotherapeutics: BCNU and bleomycin. For both drugs, cytotoxicity was increased in a synergistic manner when accompanied by ultrasound exposure. Finally, expression of a plasmid DNA encoding a GFP reporter was increased up to 30-fold when exposed to ultrasound. Altogether, these findings suggest that ultrasound may be useful to increase the efficacy of chemotherapy and gene therapy of glioma cells.

Key words: Chemotherapy; Cytotoxicity; DNA transfection; Gene therapy; Gliosarcoma brain cancer; and Ultrasound.

Vladimir G. Zarnitsyn, Ph.D.
Pavel P. Kamaev, Ph.D.
Mark R. Prausnitz, Ph.D.*

School of Chemical and Biomolecular Engineering
Georgia Institute of Technology
315 Ferst Drive
Atlanta, GA 30332-0100, USA
*prausnitz@gatech.edu

Purchase Downloadable Full-text PDF of Articles

Corporate User

$100.00

University/Academic User

$50.00

Subscription is more cost effective than purchasing PDFs on-the-fly.  Click here for details.

Member Login | Home | Editorial Board | Instructions | Subscribe | Contact Us

Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA
phone: 518-456-0784; fax: 518-452-4955; email: info@adeninepress.com
copyright © Adeninepress, All rights reserved.